Analysts expect Kyverna Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 M | 2.22 M | 2.58 M | 2.96 M | 16.69 M | 18.18 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 941,550.57 | 1.93 M | 2.26 M | 2.64 M | 15.35 M | 16.07 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 M | 2.07 M | 2.42 M | 2.80 M | 16.02 M | 17.12 M |
Analysts expect Kyverna Therapeutics, Inc. to report earnings per share of -0.74 for Q3 26, against a range of -0.80 to -0.68. The most recent reported quarter, Q2 26, came in at -0.63, a 4.5% beat against the -0.66 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.80 | -0.87 | -1.03 | -0.97 | -0.85 | -0.80 | -0.66 | -0.63 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.72 | -0.82 | -1.06 | -0.90 | -0.88 | -0.84 | -0.66 | -0.64 | -0.68 | -0.69 | -0.73 | -0.63 | -0.63 | -0.77 | -0.72 | -0.63 | ||||||||||
| Low Estimate | -0.80 | -0.92 | -1.26 | -1.06 | -0.96 | -0.94 | -0.80 | -0.68 | -0.80 | -0.81 | -0.79 | -0.75 | -0.73 | -0.85 | -0.82 | -0.69 | ||||||||||
| Consensus Estimate | -0.76 | -0.87 | -1.16 | -0.98 | -0.92 | -0.89 | -0.73 | -0.66 | -0.74 | -0.75 | -0.76 | -0.69 | -0.68 | -0.81 | -0.77 | -0.66 |
Pull Wall Street consensus for Kyverna Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KYTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KYTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KYTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();